摘要
目的观察新型吲哚美辛爱母宫内节育器(MYCuI IUD)和第二代爱母含铜宫内节育器宫内节育器(MCuⅡIUD)的临床效果.方法选择436例自愿放置MYCuIIUD和MCuⅡIUD避孕的健康育龄期妇女,根据其意愿放置2种IUD后,术后第1、3、6、12个月回访.结果 MYCu IUD组和MCuⅡIUD组12个月累计带器妊娠率分别为2/236(0.84%)、3/200(1.5%);累计脱落率分别为1/236(0.42%)、1/200(0.5%);因副作用取出率分别为2/236(0.084%),3/200(1.5%);使用效果各组差异无统计学意义(P>0.05).但MYCuIUD组早期副作用要少于MCuⅡIUD组(P=0.012).结论 MCuⅡIUD与MYCuIUD均为脱落率低、带器妊娠率低、副作用少的优点,而MYCuIUD因含吲哚美辛,早期副反应要低于MCuⅡIUD,虽然MYCuIUD花费略高,但绝大多数育龄女性都可承受,值得推广.
Objective To observe the clinical results in the new indomethacin mother love IUD （MYCuI IUD） and the second-generation copper mother love IUD （MCuΠ IUD）.Methods 436 contraceptive healthy women were voluntarily placed MYCuI IUD or MCuΠ IUD for contraception according to their wishes,then they were followed up 1,3,6,12 months after placement of IUD.Results During the 12-month following-up,the accumulative pregnancy rate was 2/236 （0.84％） and 3/200 （1.5％）,the accumulative loss rate was 1/236 （0.42％） and 1/200 （0.5 ％）,the removal rate due to side effects was 2/236 （0.084％） and 3/200 （1.5％） in MYCu IUD group and MCuΠ IUD group,respectively.Differences between groups had no statistical significance （P＞0.05）.But the early side effects were less in MYCu IUD group than MCuΠ IUD group （P =0.012） Conclusion Both MCu Π IUD and MYCuIUD have such advantages as low pregnancy rate with IUD,low loss rate and few side effects,but MYCuIUD containing indomethacin had less early side effects than MCu Π IUD,although MYCuIUD cost is a little higher,but the vast majority of women in childbearing age can bear,it is worthy of promotion.
出处
《昆明医科大学学报》
CAS
2014年第8期96-98,共3页
Journal of Kunming Medical University
基金
陕西省自然科学基金资助项目(2013JM4012)
